Back to Browse Journals » Clinical Audit » Volume 3

Sociodemographic differences in diabetic retinopathy screening; using patient-level primary care data for health equity audit

Authors Fraser SDS, Watkinson GE, Rennie CA, King D, Sanderson H, Edwards L, Roderick P

Published Date November 2011 Volume 2011:3 Pages 7—15

DOI http://dx.doi.org/10.2147/CA.S25313

Published 10 November 2011

Simon DS Fraser1, GE Watkinson2, CA Rennie3, D King2, H Sanderson2, L Edwards4, P Roderick1
1Public Health Sciences and Medical Statistics, University of Southampton, Southampton General Hospital, Southampton, 2NHS Southampton City, Southampton, 3Southampton Eye Unit, Southampton General Hospital, Southampton, 4NHS Hampshire, Eastleigh, Hampshire, UK

Background: The prevalence of diabetes is increasing worldwide and there is inequality in the distribution of diabetic complications. Diabetic retinopathy is the leading cause of blindness in adults of working age in the UK, and certain risk factors are recognized. Retinopathy screening in the UK involves annual digital retinal photography and image grading. Auditing equity in retinopathy screening poses unique challenges, and screening program data are often incomplete for variables relevant to equity. Using two sources of patient-level primary care data, we conducted a health equity audit comparing the access and uptake of screening between groups of people with diabetes in each of three screening programs covering this area of southern England.
Methods: A patient-level dataset using data from general practices and a combined health record was used to compare dimensions of equity (gender, age, length of time since diabetes diagnosis, type of diabetes, presence of hypertension, socioeconomic deprivation, ethnicity, and screening program) between people with and without a record of retinopathy screening within three years in Hampshire and the Isle of Wight, UK.
Results: Anonymized data for 70,004 people with diabetes were obtained from 205 (88%) general practices. In total, 62,836 people (89.8%) had a record of screening within three years and 7168 (10.2%) did not. Lower uptake of screening was independently associated with the youngest and oldest age groups (compared with 50–79-year-olds), recent diabetes diagnosis, and deprived areas. Diagnosed hypertension was positively associated with screening.
Conclusion: Evaluating equity in screening programs is important to help reduce inequalities. We found evidence of inequity in access and uptake of retinopathy screening. Primary care data contained more information than screening program data. Using a combined health record was more efficient than obtaining data directly from general practices, but data were incomplete for deprivation measures at the time of this audit. Our audit informed subsequent efforts to improve equity in local diabetic retinopathy screening services.

Keywords: inequality, diabetes, eye, complications, screening

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Readers of this article also read:

Deposit buildup on prosthetic eye material (in vitro) and its effect on surface wettability

Pine KR, Sloan B, Han KYI, Swift S, Jacobs RJ

Clinical Ophthalmology 2013, 7:313-319

Published Date: 13 February 2013

Retrospective analysis of KRAS status in metastatic colorectal cancer patients: a single-center feasibility study

Montomoli J, Hamilton-Dutoit SJ, Frøslev T, Taylor A, Erichsen R

Clinical and Experimental Gastroenterology 2012, 5:167-171

Published Date: 18 September 2012

The evaluation and optimal use of rituximab in lymphoid malignancies

Robak T, Robak P, Smolewski P

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:1-16

Published Date: 4 January 2012

Time-consuming eyelashes: an audit of trichiasis management

Mona Khandwala, Sarju Dey, Muddassar Hussain, et al

Clinical Audit 2010, 2:83-87

Published Date: 21 July 2010

Spontaneous corneal perforation in a patient with lamellar ichthyosis and dry eye

Burak Turgut, Orhan Aydemir, Murat Kaya, et al

Clinical Ophthalmology 2009, 3:611-613

Published Date: 4 November 2009

Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer

Francesco Di Costanzo, Silvia Gasperoni, Virginia Rotella, Federica Di Costanzo

OncoTargets and Therapy 2009, 2:179-188

Published Date: 7 July 2009

The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer

Thomas Powles, Siobhan McFaul, Justin Stebbing, Peter Wilson, Tim Oliver et al

OncoTargets and Therapy 2008, 1:35-39

Published Date: 30 September 2008

Regulation of the renin–angiotensin system in coronary atherosclerosis: A review of the literature

Ramadan A Hammoud, Christopher S Vaccari, Sameer H Nagamia, Bobby V Khan

Vascular Health and Risk Management 2007, 3:937-945

Published Date: 15 January 2007